Decreased NK cell functions in obesity can be reactivated by fat mass reduction

Obesity

Volumn 23, Issue 11, 2015, Pages 2233-2241

  Jahn, Janine ^a   Spielau, Marco ^a   Brandsch, Corinna ^a   Stangl, Gabriele I ^a   Delank, Karl Stefan ^a   Bähr, Ina ^a   Berreis, Tobias ^a   Wrann, Christiane D ^b   Kielstein, Heike ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CD56 ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DIET; EXERCISE; FAT MASS; FEMALE; FITNESS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; METABOLISM; NATURAL KILLER CELL; NUTRITION; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; WEIGHT REDUCTION; BLOOD; CONTROLLED CLINICAL TRIAL; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION; WEIGHT LOSS PROGRAM;

ADIPOKINES; ADULT; ANTHROPOMETRY; EXERCISE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEPTIN; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OBESITY; SIGNAL TRANSDUCTION; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84946492239     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21229     Document Type: Article

References (40)

1. OECD. OECD Factbook 2013: Economic, Environmental and Social Statistics. Overweight and Obesity. OECD Publishing; Paris, 2013.
2. Calle EE, Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
3. Trinchieri G., Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
4. Vivier E, Raulet DH, Moretta A, et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44-49.
5. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A., Surface NK receptors and their ligands on tumor cells. Semin Immunol 2006; 18: 151-158.
6. Koch J, Steinle A, Watzl C, Mandelboim O., Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol 2013; 34: 182-191.
7. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000; 356: 1795-1799.
8. Kershaw EE, Flier JS., Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
9. Bluher M., Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009; 117: 241-250.
10. Wrann CD, Laue T, Hubner L, et al., Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab 2012; 302: E108-E116.
11. Huebner L, Engeli S, Wrann CD, Goudeva L, Laue T, Kielstein H., Human NK cell subset functions are differentially affected by adipokines. PLoS One 2013; 8: e75703.
12. Nave H, Mueller G, Siegmund B, et al., Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008; 149: 3370-3378.
13. Lautenbach A, Wrann CD, Jacobs R, Muller G, Brabant G, Nave H., Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals. Obesity (Silver Spring) 2009; 17: 1848-1855.
14. Kelley DS, Daudu PA, Branch LB, Johnson HL, Taylor PC, Mackey B., Energy restriction decreases number of circulating natural killer cells and serum levels of immunoglobulins in overweight women. Eur J Clin Nutr 1994; 48: 9-18.
15. Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA., Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc 1998; 30: 1666-1671.
16. Nieman DC, Nehlsen-Cannarella SL, Henson DA, et al., Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc 1998; 30: 679-686.
17. Moulin CM, Marguti I, Peron JP, Halpern A, Rizzo LV., Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity. Obes Surg 2011; 21: 112-118.
18. Schwartz DR, Lazar MA., Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 2011; 22: 259-265.
19. Panee J., Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine 2012; 60: 1-12.
20. Maki G, Klingemann HG, Martinson JA, Tam YK., Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res 2001; 10: 369-383.
21. De Pergola G, Silvestris F., Obesity as a major risk factor for cancer. J Obes 2013; 2013: 291546.
22. Shields M, Tremblay MS, Connor Gorber S, Janssen I., Measures of abdominal obesity within body mass index categories, 1981 and 2007-2009. Health Rep 2012; 23: 33-38.
23. Heer M, Baecker N, Wnendt S, Fischer A, Biolo G, Frings-Meuthen P., How fast is recovery of impaired glucose tolerance after 21-day bed rest (NUC study) in healthy adults? Sci World J 2014; 2014: 803083.
24. Jackson AS, Stanforth PR, Gagnon J, et al., The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. Int J Obes Relat Metab Disord 2002; 26: 789-796.
25. White UA, Tchoukalova YD., Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta 2013; 1842: 377-392.
26. Considine RV, Sinha MK, Heiman ML, et al., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
27. Zhou Y, Rui L., Leptin signaling and leptin resistance. Front Med 2013; 7: 207-222.
28. Haffner SM, Miettinen H, Mykkanen L, Karhapaa P, Rainwater DL, Laakso M., Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes Relat Metab Disord 1997; 21: 393-399.
29. Cui H, Cai F, Belsham DD., Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and ATF1. FASEB J 2006; 20: 2654-2656.
30. Fantuzzi G, Faggioni R., Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-446.
31. Laue T, Wrann CD, Hoffmann-Castendiek B, Pietsch D, Huebner L, Kielstein H., Altered NK cell function in obese healthy humans. BMC Obesity 2015; 2: 1.
32. De Maria A, Bozzano F, Cantoni C, Moretta L., Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci USA 2011; 108: 728-732.
33. Bekisz J, Sato Y, Johnson C, Husain SR, Puri RK, Zoon KC., Immunomodulatory effects of interferons in malignancies. J Interferon Cytokine Res 2013; 33: 154-161.
34. Nakashima H, Miyake K, Clark CR, et al., Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors. Cancer Immunol Immunother 2012; 61: 1081-1092.
35. Amati F, Dube JJ, Shay C, Goodpaster BH., Separate and combined effects of exercise training and weight loss on exercise efficiency and substrate oxidation. J Appl Physiol (1985) 2008; 105: 825-831.
36. Ito H, Ohshima A, Tsuzuki M, et al., Effects of increased physical activity and mild calorie restriction on heart rate variability in obese women. Jpn Heart J 2001; 42: 459-469.
37. Walsh NP, Gleeson M, Shephard RJ, et al., Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011; 17: 6-63.
38. Pedersen BK, Rohde T, Ostrowski K., Recovery of the immune system after exercise. Acta Physiol Scand 1998; 162: 325-332.
39. Rundqvist H, Augsten M, Stromberg A, et al., Effect of acute exercise on prostate cancer cell growth. PLoS One 2013; 8: e67579.
40. McTiernan A., Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008; 8: 205-211.